Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2015 Mar 30;5:9438. doi: 10.1038/srep09438

Using brachial-ankle pulse wave velocity to screen for metabolic syndrome in community populations

Guanghua Wang 1,*, Liang Zheng 2,*, Xiankai Li 3, Juanli Wu 4, Lijuan Zhang 4, Jie Zhang 4, Liling Zou 4, Xin Li 2, Yi Zhang 3, Qian Zhou 1, Huimin Fan 2, Yang Li 5,a, Jue Li 4,b
PMCID: PMC4377586  PMID: 25820176

Abstract

The aim of this study is to investigate the viability of using brachial-ankle pulse wave velocity (baPWV) as a primary tool to screen metabolic syndrome (MetS), and to explore the risk factors of MetS in community populations. A total of 1914 subjects completed medical examination in Shanghai. BaPWV was significantly associated with the components of MetS. The area under curve (AUC) and its 95% confidence interval (CI) in total group were 62.50% and 60.00%–65.30% with the appropriate cut-off point being 1435 cm/sec. The AUC (95%CI) of three subgroups (40–50 yrs, 50–60 yrs and over 60 yrs group) were 75.30% (67.48%–83.35%), 63.35% (58.96%–67.60%), 55.37% (51.19%–60.01%), respectively. A clear pattern surfaced in the process of investigation: the younger were the subjects group, the better receiver operating characteristic (ROC) efficacy would emerge; and the higher sensitivity was, the better negative predictive value (NPV) would be. Male gender, high baPWV values, elevated uric acid (UA) and excess hypersensitive C reaction protein (hs-CRP) levels were stayed in the two regression models as the independent risk factors for MetS. We conclude that baPWV may serve as a potential screening tool for MetS at the cut-off point of 1435 cm/sec.


Brachial-ankle pulse wave velocity (baPWV) is a promising yet relatively simple test that measures the stiffness of both aortic and peripheral arteries1,2 and a number of research groups propose using this technique to detect subclinical atherosclerotic changes. Many studies have demonstrated its reproducibility and validity3,4,5, with some investigators advocating that baPWV is not only an ideal marker for vascular damage6,7 but also a valuable predictor to the mortality resulted from cardiovascular diseases8. Due to the non-invasive nature and simplicity in performing all the measurements, baPWV has a potential screening value for vascular injuries in community populations.

MetS involves a combination of factors that increases the risk of cardiovascular diseases and type 2 diabetes, and its prevalence is increasing in many countries and in China alike. These risk factors include obesity, dysglycemia, raised blood pressure (BP), elevated triglyceride (TG) level, and low high-density lipoprotein cholesterol (HDL-C) level9. With the increasing prevalence of MetS in China, MetS has seriously burdened the society and, in particular, the families of those affected subjects as reported in literature10,11.

Early detection and treatment of MetS have been proven to reduce further cardiovascular disease morbidity and mortality12. However, with no immediate physical symptoms or medical problems associated with this disorder, the diagnosis of MetS remains challenging. The most widely recognized metabolic criteria (lipid profile, BP and glucose level) are commonly measured during hospitalization of patients13. The cost and availability of these diagnostic tests have hampered the mass screening in high-risk populations using above indices, especially in underdeveloped areas and developing countries. Hence, we launched this study to investigate the feasibility of using baPWV in screening for MetS in community populations. The current study focused on the efficacy of a non-invasive baPWV examination in screening individuals at high risk of MetS. Since it is well known that the incidence of MetS increases with age, we explored the screening capability of the method and appropriate cut-off point.

Methods

Study population

Methods used in the present study were carried out in accordance with the approved guideline. At the same time, all experimental protocols were approved by the Ethics Committee of Tongji University, and all the participants signed informed consent.

Individuals were included if they met all the following criteria: (1) subjects with age 40 years and above; (2) subjects who were conventional residents in Lujiazui community, Shanghai; (3) individuals without hypertension crisis, multiple system organ failure, or other disease that may prevent them from measuring baPWV. Subjects were excluded if they did not meet above criteria. This community-based study adopted a cluster sampling scheme and randomly recruited a total of 2000 individuals between June 2009 and January 2010. Among these participants, 1914 subjects completed the lab tests and personal health and medical questionnaires. The response rate was 95.70%.

Anthropometric index and lab tests

Body mass index (BMI) was calculated as body weight in kilograms divided by the square of the body height in meters (kg/m2). The systolic and diastolic blood pressures (SBP and DBP, respectively) were obtained from the left arms of seated patients with an automatic BP monitor after 20 minutes of rest. Blood was drawn from the subjects in the morning after a 12-hour overnight fasting and was sent for analysis within four hours of collection. Biochemical markers such as uric acid (UA), total cholesterol (TC), TG, brain natriuretic peptide (BNP), hypersensitive C reaction protein (hs-CRP), homocyteine (Hcy), HDL-C, low density lipoprotein cholesterol (LDL-C), glycosylated hemoglobin Alc (HbAlc), and fasting plasma glucose (FPG) levels were analyzed using a biochemical auto analyzer in the Department of Clinical Laboratory, Shanghai East Hospital, Tongji University School of Medicine.

Lifestyle behaviors

In the present study, the term ‘not married’ referred to both unmarried and divorced individuals, ‘low education level’ meant less-than-12 years of full time education, and ‘high education level’ denoted equal to or greater than 12 years education. The subjects' current smoking status was derived from affirmative responses to the question “Are you a regular smoker now?” For participants reporting a history of smoking, those who had smoked within the past 6 months were defined as ‘current smokers’; while those who had not smoked within the past 6 months as ‘non-smokers’14. Participants were also asked “How many alcoholic drinks do you have each week?” and “How many days each week do you usually drink alcohol?” These variables were used to determine the approximate number of alcoholic drinks consumed each day by the participant. A binary variable was constructed to distinguish between the participants consuming less than two and those drinking at least two alcoholic drinks every day.

Definition of MetS

The definition15,16 of MetS was as following:(1) Required criteria: BMI ≥ 25 kg/m2 (waist circumference was not available in this study); (2) Plus any two of the following four factors: a. Elevated TG level: ≥1.7 mmol/L (or 150 mg/dL); b. Reduced HDL-C level: <40 mg/dL (male) or 50 mg/dL (female); c. Raised BP: SBP ≥ 130 mmHg or DBP ≥ 85 mmHg, d. Elevated FPG level: ≥5.6 mmol/L (or 100 mg/dL).

BaPWV measurement

A clinical device (baPWV-form) was used to automatically and simultaneously chronicle BP in both arms and ankles and document waves of the brachial and posterior tibial arteries using an automated oscillometric method17,18,19. BaPWV value can easily be checked through VP-1000 automated PWV/ABI analyzer (model VP-1000; Nippon Colin Ltd., Komaki, Japan). These values were measured after individuals had rested for at least 5 minutes. In case the values of baPWV obtained on the right and left sides were not identical20, we adopted the average value of left and right baPWV.

Multivariate model

The adjusted variables included in Model 1 were baPWV, gender, educational level, income level, marriage status, UA, Hs-CRP and BNP, as included in the Model 2 were baPWV, gender, educational level, income level, marriage status, smoking, alcohol drinking, UA, hs-CRP and BNP.

Statistical analysis

Continuous data were expressed as mean and standard deviation (SD). For the continuous variables, t-test was employed to analyze the difference between MetS and non-MetS groups. If the variances were not equal between two groups, nonparametric test was used instead of t-test. For the classified variables, a Chi-squared test (χ2-test) was conducted to show the ratio difference between the two groups. Receiver operating characteristic (ROC) curve21,22 was constructed to determine the optimal baPWV threshold in order to discriminate MetS and non-MetS individuals. Afterwards, the baPWV value with the highest sum of sensitivity and specificity was identified as the cut-off point. A step-wise logistic regression analysis was conducted to explore the risk factors of MetS. All statistical analyses were performed using the SPSS17.0 (SPSS Inc., Chicago, IL, USA) software package. A two-tailed P value of <0.05 was considered statistically significant.

Results

Demographic characteristics and correlation between baPWV and the components of MetS

The ages of all subjects traverse from 40 to 89 years with mean age being 59.46 ± 8.88 years. As shown in Table 1, the subjects in MetS group exhibit higher mean age and BMI compared to those in non-MetS group (P < 0.01). Other statistically significant differences have not been detected between the two groups of subjects, excepting the diabetes history and alcohol drinking status.

Table 1. Comparison of demographic characteristics between MetS and Non-MetS group.

Variables MetS group Non-MetS group t/χ2 P
mean ± SD mean ± SD
Age (years) 60.7 ± 8.9 59.0 ± 8.8 −3.58 0.001
BMI (kg/m2) 27.65 ± 2.31 22.95 ± 2.66 −34.37 0.001
Gender [n(%)]        
 Male 175(35.64) 444(31.20) 3.28 0.069
 Female 316(64.36) 979(68.80)    
Marital status [n(%)]        
 Not married 53(10.79) 144(10.12) 0.18 0.671
 Married 438(89.21) 1279(89.88)    
Income(RMB per month) [n(%)]        
 Low 436(88.80) 1249(87.77) 0.36 0.545
 High 55(11.20) 174(12.23)    
Education Level [n(%)]        
 Low 409(83.30) 1164(81.80) 0.56 0.453
 High 82(16.70) 259(18.20)    
History of diabetes [n(%)]        
 Yes 69(14.18) 86(6.11) 31.84 0.001
 No 417(85.82) 1329(93.89)    
Smoking [n(%)]        
 Yes 372(75.76) 1126(79.13) 2.43 0.119
 No 119(24.24) 297(20.87)    
Drinking [n(%)]        
 Yes 403(82.08) 1232(86.58) 5.93 0.015
 No 88(17.92) 191(13.42)    

Abbreviations: BMI, body mass index;

Marital status: not married refers to both unmarried and divorced individuals;

Income level: high level means greater than or equal to 5000 RMB per month;

Education level: low education level means full time education of less than 12 years, and high level means greater than or equal to 12 years.

Our results demonstrate that there are significant differences between the two groups of subjects with nearly all the measured biochemical characteristics, excluding BNP, Hcy and augmentation index (AI) (Table 2). The subjects in the non-MetS group display a significantly higher ankle-brachial index (ABI) than those in the MetS group (t = 4.87, P < 0.01).

Table 2. Comparison of biochemical characteristics between MetS and Non-MetS group.

Variables MetS group Non-MetS group t/Z P
mean SD mean SD
baPWV (cm/sec) 1677.60 323.14 1554.80 338.52 −6.99 0.001
UA (mg/dL) 350.38 80.88 304.47 76.20 −11.33 0.001
TC (mmol/L) 5.34 0.99 5.17 0.96 −3.19 0.001
TG* (mmol/L) 2.01 (1.56, 2.69) 1.31 (0.97, 1.81) −10.59 0.001
BNP* (ng/L) 53.00 (29.00, 93.00) 54.00 (32.00, 87.00) 0.02 0.985
Hs-CRP (mg/dL) 2.73 2.83 1.90 3.30 −4.96 0.001
Hcy (mmol/L) 13.02 8.03 12.27 7.34 −1.73 0.060
AI 84.42 12.23 85.68 13.11 1.86 0.063
ABI 1.09 0.08 1.11 0.07 4.87 0.001

*Indicating the variances was not equal between two groups. Data was expressed as median and quartiles value;

Abbreviations: baPWV, brachial-ankle pulse wave velocity; UA, uric acid; TC, total cholesterol; TG, triglyceride; BNP, brain natriuretic peptide; Hs-CRP, hypersensitive C reaction protein; Hcy, homocyteine; AI, augmentation index; ABI, ankle-brachial index.

Conspicuously, the results in Table 3 prove a negative correlation between baPWV and HDL-C (r = −0.09, P < 0.01) and a positive relationship between baPWV and other variables in all subjects, while baPWV values illustrate a strong relationship with SBP, with the coefficient value being 0.60 (P < 0.01) (Figure 1).

Table 3. Correlation between baPWV and the components of MetS.

Variables r P
BMI (kg/m2) 0.11 0.001
SBP (mm Hg) 0.60 0.001
TG (mmol/L) 0.14 0.001
HDL-C (mmol/L) −0.09 0.001
LDL-C (mmol/L) 0.05 0.027
HbA1c (%) 0.19 0.001
Glucose (mmol/L) 0.24 0.001

Abbreviations: BMI, body mass index; SBP, systolic BP; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; HbA1c, glycosylated hemoglobin A1c.

Figure 1. Simple linear correlation between baPWV and other variables.

Figure 1

(a) r = 0.60, P = 0.001; (b) r = 0.24, P = 0.001.

ROC curve and its cut-off point

Figure 2 presents the ROC curves in total group and subgroups (three age ranges). The AUC (95%CI) in total group is 62.50% (60.00%–65.30%) with the appropriate cut-off point being 1435 cm/sec. The AUC in three subgroups (40–50 yrs, 50–60 yrs and over 60 yrs group) are 75.30%, 63.35% and 55.37%, respectively.

Figure 2. ROC curve and AUC.

Figure 2

(a) Total group: AUC = 62.50%, 95%CI of AUC: 60.00%–65.30%, Cut-off point = 1435 cm/sec, Sensitivity = 76.06%, Specificity = 50.43% (Limitation), Youden index = 0.26; (b) 40–50 yrs group: AUC = 75.30%, 95%CI: 67.48%–83.35%; (c) 50–60 yrs group: AUC = 63.35%, 95%CI: 58.96%–67.60%; (d) >60 yrs group: AUC = 55.37%, 95%CI: 51.19%–60.01%.

Table 4 displays the AUC, cut-off point, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and Youden index in total group and all three subgroups. The baPWV at cut-off point of 1435 cm/sec has resulted in the highest Youden index in total group, with a corresponding sensitivity being 76.06%, specificity 50.43%, PPV 33.84% and NPV 86.34%. At the same time, its false negative rate is 23.94%.

Table 4. Areas under the ROC curve, cut offs, sensitivity, specificity, PPV, NPV and Youden index of baPWV by age groups.

Age AUC (%) (95%CI) P Cut-off point Sensitivity (%) Specificity (%) PPV (%) NPV (%) Youden index
40–50 (yrs) 75.30 (67.48–83.35) 0.001 1355 75.55 66.29 42.76 89.05 0.42
50–60 (yrs) 63.35 (58.96–67.60) 0.001 1427 68.35 53.28 32.78 83.47 0.22
>60 (yrs) 55.37 (51.19–60.01) 0.018 1680 65.33 48.87 30.03 80.87 0.14
Total 62.50 (60.00–65.30) 0.001 1435 76.06 50.43 33.84 86.34 0.26

Abbreviations: AUC, areas under the ROC curve; PPV, positive predictive value; NPV, negative predictive value.

Risk factors of MetS in multiple logistic regression model

The MetS status is considered as a dependent variable, the same variables of gender, baPWV, UA and hs-CRP enter into two regression models (Model 1 and Model 2), the regression coefficients in Model 1 are 0.40, 0.73, 0.01 and 0.06, respectively; and the values turn into 0.45 0.73, 0.01 and 0.06, respectively, in Model 2 (Table 5). The Odds Ratio (OR) value (95% CI) of baPWV is the highest in both models, being 2.08 (1.60–2.71) and 2.68 (1.60–2.71), respectively (Figure 3).

Table 5. Risk factors and parameters of multiple logistic regression model.

Variables ßd SE Wald P OR 95%CI
Model1a            
Gender 0.40 0.13 9.04 0.001 1.49 (1.15–1.93)
BaPWVb 0.73 0.13 30.15 0.001 2.08 (1.60–2.71)
UA 0.01 0.01 92.23 0.001 1.02 (1.01–1.03)
Hs-CRP 0.06 0.01 12.92 0.001 1.06 (1.03–1.10)
Model2c            
Gender 0.45 0.17 20.91 0.001 1.58 (1.11–2.23)
BaPWVb 0.73 0.13 30.24 0.001 2.68 (1.60–2.71)
UA 0.01 0.00 90.69 0.001 1.01 (1.01–1.02)
Hs-CRP 0.06 0.01 12.89 0.001 1.07 (1.03–1.11)

aAdjusted variables in model1: baPWV, gender (male vs. female), educational level, income level, marriage status, UA, Hs-CRP and BNP;

bBaPWV abnormal range: ≥1435 cm/sec, normal range, <1435 cm/sec;

cAdjusted variables in model2: baPWV, gender, educational level, income level, marriage status, smoking, alcohol drinking, UA, hs-CRP and BNP;

dRegression coefficient.

Figure 3. OR value and its 95%CI in different models.

Figure 3

(a) Model 1; (b) Model 2.

When baPWV data are divided into four factions of quartiles and the adjusted variables are same as those in Model 2, the OR and its 95%CI are determined by logistic regression analysis (Table 6). Compared with the readings in lowest baPWV quartile, the adjusted OR (95%CI) of having MetS in baPWV quartiles 2, 3, 4 are 1.60 (1.12–2.27), 1.63 (1.13–2.35), and 2.56 (1.83–3.57) in the total group, respectively.

Table 6. Odds ratio and 95% CI of baPWV for MetS in regression model.

Quartile Male Female Total
OR 95%CI OR 95%CI OR 95%CI
Q1 1.00 Reference 1.00 Reference 1.00 Reference
Q2 1.40 0.74–2.65 1.66 1.08–2.55 1.60 1.12–2.27
Q3 1.66 0.89–3.10 1.52 0.95–2.41 1.63 1.13–2.35
Q4 2.76 1.55–4.92 2.25 1.48–3.42 2.56 1.83–3.57

Adjusted for baPWV, gender, educational level, income level, marriage status, smoking, alcohol drinking, UA, hs-CRP and BNP; The baPWV was divided into four groups by quartile (<1378, 1378–1569, 1569–1818, ≥1818 cm/sec in men; <1324, 1324–1490, 1490–1738, ≥1738 cm/sec in women; <1336, 1336–1516, 1516–1704, ≥1704 cm/sec in total).

Discussion

With the change of living rhythm and dietary style in China, the prevalence of MetS has drastically increased in the last decade throughout the Country. Using the International Diabetes Federation (IDF) definition, Hu XS et al23 reported that the prevalence of MetS had been 17.84% in 2005 in Jiangsu Province. In 2010, research carried out by Shao YQ et al24 indicated that the prevalence of MetS had been 19.21% in Shanghai area derived from using the same definition. Yet the society lacks a convenient, cost-efficient method to screen for the high-risk MetS individuals in communities.

Brachial-ankle pulse wave velocity (baPWV) is a newly-emerged technique that is capable of evaluating arterial stiffness in a relatively swift and economic way, predicting the cardiovascular risk factors in patients. The subjects with arteriosclerosis share some common pathology and clinical manifestations with subjects suffering MetS; and the existence of a strong association between MetS and arterial stiffness has been demonstrated in many studies25,26,27. In addition, a number of reports have verified that the mechanisms underlying the association include, but not limited to, the common inflammatory pre-cursors and oxidative stress appearance28. The simultaneous occurrence of MetS and proinflammatory and oxidative stress markers increases the likelihood of arterial stiffness29. Since the baPWV measurements increase before atherosclerosis30, we assume that baPWV is likely to be a potential screening tool for MetS.

Our results in this report show that baPWV values correlate with all components of MetS, substantiating the outcomes reported by Zhao WW et al30. In general, our data suggest that the prevalence of MetS is 25.65% in the middle-aged and elderly populations in Shanghai area. Although there are some differences in selecting participants with the above studies, our results are consistent with theirs, and the increasing prevalence of MetS in the Chinese population is unquestionably plain.

Thus far, there is not a generally accepted cut-off point of baPWV in screening individuals at risk of MetS. In this study, the discriminatory value of baPWV measurements for MetS has been established in the community population-based study with 1914 subjects. More importantly, we have determined an optimal cut-off point of baPWV (1435 cm/sec), which could be a potential index variable to screen for high risk individuals of MetS in local Chinese populations.

Moreover, besides establishing the useful cut-off point of baPWV, we have calculated baPWV quartiles in logistic model as well. With the increase of baPWV in quartiles, the OR of baPWV for MetS boosts as well, confirming the similar results of an earlier study31. The difference between two genders has already been reported in our previous publication32.

The ROC curve attained from our results has demonstrated that baPWV may be considered as a screening index to discriminate between those with and without MetS. In total group, the AUC (95%CI) is 62.50% (60.00%–65.30%) and the optimal cut-off point of baPWV for MetS is 1435 cm/sec, which is higher than Yamashina's suggestion20, but lower than Lin WY's implication31. It is noteworthy that the false negative rate (23.94%) is lower than the previous reports, meaning omission of a diagnostic index is unlikely. In addition, it is interesting to find that the younger a subject's age is, the better ROC efficacy he/she acquires; the higher sensitivity is, the better NPV surfaces. Similarly, the older age is, the higher baPWV appears; the lower specificity is, the lower PPV emerges. This trend is consistent with the results reported by Wang F33, who has tried to predict the MetS with BMI. However, our AUC outcome in different subgroups is better than that of the previous report33, supporting the notion that baPWV has a better capability for screening MetS than BMI, waist circumference(WC) or waist to hip ratio (WHR).

Analysis of multiple logistic regressions demonstrates that gender, baPWV, UA and hs-CRP are the high risk factors of MetS, consistent with the results of other reports29,34,35. Individuals with higher baPWV are twice more likely to have MetS compared to those with lower baPWV. Hyperuricemia is another significant predictor of MetS36, and chronic low-grade inflammation in MetS is an underlying mechanism mediated in part by the pro-inflammatory properties of UA37,38 and may trigger the elevated baPWV. UA has been found to play two roles in promoting inflammation: as a monosodium urate crystal and as a soluble factor34. Inflammation (assessed by hs-CRP) may cling to a possible, underlying relationship between baPWV and MetS31,39.

It should be pointed out that sensitivity of this screening scheme may be underestimated. Since obesity is an essential diagnostic criterion for MetS and the condition may lead to other metabolic disorders40,41, a possible limitation exists as we adopt BMI as a surrogate variable for waist circumference in defining people with central obesity42. The fact that most Asians rather have normal BMI and high WHR (central obesity) may cause a high false negative rate.

Besides, there are several limitations in the study. Firstly, the study participants consist of middle-aged and elderly individuals, and the AUC is likely underestimated, since the younger age the subgroup members are of, the better ROC efficacy turns up. Secondly, the specificity may not be optimal and most advantageous, and further studies are warranted to verify this. Thirdly, we cannot prove the causality between baPWV and MetS since this is a cross-section study. However, we have found a close association between baPWV and MetS as well as the MetS components, which are also risk factors of cardiovascular diseases. Prospective studies are needed to establish the time sequence in the relationship between UA, hs-CRP, baPWV, and MetS, and to fine tune and improve the screening procedures.

In conclusion, baPWV is a potential index variable to screen high risk individuals of MetS and we would need further work to test the utility as a screening tool. Moreover, a higher baPWV, hs-CRP, UA level, as well as male gender are the independent risk factors for MetS.

Acknowledgments

This study was supported by grants from the National Nature Science Foundation of China (No. 81170325); International Science & Technology Cooperation Program of China (No. 2011DFB30010); National Nature Science Foundation of China (No. 81102203); Fundamental Research Funds for the Central Universities (Study on the key technology of disaster warning and relief for rural remote areas. National Key Basic Research Program of China (No. 2013CB531100).

Footnotes

The authors declare no competing financial interests.

Author Contributions J.L. and Y.L. proposed the conceptual idea and provided financial support through grant application. G.W. and L.Z. designed and carried out the study, and analyzed the data and wrote the manuscript. X.L., J.W., L.Z., J.Z., L.Z., X.L., Y.Z., Q.Z. and H.F. participated in discussing the results and in writing the manuscript. All authors reviewed the manuscript.

References

  1. Yamashina A. et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens. Res. 25, 359–364 (2002). [DOI] [PubMed] [Google Scholar]
  2. Tomiyama H. et al. Influences of age and gender on results of noninvasive brachial-ankle pulse wave velocity measurement--a survey of 12517 subjects. Atherosclerosis 166, 303–309 (2003). [DOI] [PubMed] [Google Scholar]
  3. Figueroa A. et al. Effects of diet and/or low-intensity resistance exercise training on arterial stiffness, adiposity, and lean mass in obese postmenopausal women. Am. J. Hypertens. 26, 416–423 (2013). [DOI] [PubMed] [Google Scholar]
  4. Nakamura M. et al. Brachial-ankle pulse wave velocity as a risk stratification index for the short-term prognosis of type 2 diabetic patients with coronary artery disease. Hypertens. Res. 33, 1018–1024 (2010). [DOI] [PubMed] [Google Scholar]
  5. Chen S. C. et al. Brachial-ankle pulse wave velocity and rate of renal function decline and mortality in chronic kidney disease. Clin. J. Am. Soc. Nephrol. 6, 724–732 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hsu S. R. et al. Risk factors of accelerated progression of peripheral artery disease in hemodialysis. Kaohsiung J. Med. Sci. 29, 82–87 (2013). [DOI] [PubMed] [Google Scholar]
  7. Doba N. et al. Changes in ankle brachial pulse wave velocity during a five-year follow-up period in older Japanese adults: sub-analysis results of the health research volunteer study in Japan. Intern. Med. 52, 21–27 (2013). [DOI] [PubMed] [Google Scholar]
  8. Lehmann E. D., Riley W. A., Clarkson P. & Gosling R. G. Non-invasive assessment of cardiovascular disease in diabetes mellitus. Lancet 350 Suppl 1, SI14–19 (1997). [DOI] [PubMed] [Google Scholar]
  9. Alberti K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009). [DOI] [PubMed] [Google Scholar]
  10. Wu S. et al. Association between erythrocyte parameters and metabolic syndrome in urban Han Chinese: a longitudinal cohort study. BMC Public Health 13, 989 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Workalemahu T., Gelaye B., Berhane Y. & Williams M. A. Physical activity and metabolic syndrome among Ethiopian adults. Am. J. Hypertens. 26, 535–540 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grundy S. M. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735–2752 (2005). [DOI] [PubMed] [Google Scholar]
  13. Patel P. V., Gilski D. & Morrison J. Using waist circumference to screen for metabolic syndrome in an inpatient population. Crit Pathw Cardiol 9, 152–155 (2010). [DOI] [PubMed] [Google Scholar]
  14. Tuomilehto J. et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 357, 848–851 (2001). [DOI] [PubMed] [Google Scholar]
  15. Sabo R. T. et al. Parental and offspring associations of the metabolic syndrome in the Fels Longitudinal Study. Am. J. Clin. Nutr. 96, 461–466 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Alberti K. G., Zimmet P. & Shaw J. The metabolic syndrome--a new worldwide definition. Lancet 366, 1059–1062 (2005). [DOI] [PubMed] [Google Scholar]
  17. Su H. M. et al. Impact of systolic time intervals on the relationship between arterial stiffness and left ventricular hypertrophy. Atherosclerosis 223, 171–176 (2012). [DOI] [PubMed] [Google Scholar]
  18. Chen S. C., Chang J. M., Tsai Y. C., Su H. M. & Chen H. C. Brachial-ankle pulse wave velocity and brachial pre-ejection period to ejection time ratio with renal outcomes in chronic kidney disease. Hypertens. Res. 35, 1159–1163 (2012). [DOI] [PubMed] [Google Scholar]
  19. Su H. M. et al. Association of brachial-ankle pulse wave velocity, ankle-brachial index and ratio of brachial pre-ejection period to ejection time with left ventricular hypertrophy. Am. J. Med. Sci. 347, 289–294 (2014). [DOI] [PubMed] [Google Scholar]
  20. Yamashina A. et al. Brachial-ankle pulse wave velocity as a marker of atherosclerotic vascular damage and cardiovascular risk. Hypertens. Res. 26, 615–622 (2003). [DOI] [PubMed] [Google Scholar]
  21. Guo X. et al. Sensitivity and specificity of ankle-brachial index for detecting angiographic stenosis of peripheral arteries. Circ. J. 72, 605–610 (2008). [DOI] [PubMed] [Google Scholar]
  22. Park K. H. et al. Clinical significance of framingham risk score, flow-mediated dilation and pulse wave velocity in patients with stable angina. Circ. J. 75, 1177–1183 (2011). [DOI] [PubMed] [Google Scholar]
  23. Hu X. S. et al. [Study on the prevalence of metabolic syndrome among 35–74 year-olds in Jiangsu province]. Chin J Epidemiol 27, 751–756 (2006). [PubMed] [Google Scholar]
  24. Shao Y. Q. et al. Epidemiologyical features of metabolic syndrome in 35–74 year-old residents in suburban areas of Shanghai. Chinese general practice 14, 2069–2071 (2011). [Google Scholar]
  25. Tok D. et al. Increased epicardial fat thickness is associated with low grade systemic inflammation in metabolic syndrome. Turk Kardiyol Dern Ars 40, 690–695 (2012). [DOI] [PubMed] [Google Scholar]
  26. Satoh H., Kishi R. & Tsutsui H. Metabolic syndrome is a significant and independent risk factor for increased arterial stiffness in Japanese subjects. Hypertens. Res. 32, 1067–1071 (2009). [DOI] [PubMed] [Google Scholar]
  27. Li C. I. et al. Metabolic syndrome is associated with change in subclinical arterial stiffness: a community-based Taichung community health study. BMC Public Health 11, 808 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zhang Y. et al. Inflammation and oxidative stress are associated with the prevalence of high aankle-brachial index in metabolic syndrome patients without chronic renal failure. Int. J. Med. Sci. 10, 183–190 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Weng C. et al. Age- and gender dependent association between components of metabolic syndrome and subclinical arterial stiffness in a Chinese population. Int. J. Med. Sci. 9, 730–737 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Zhao W. W. et al. Serum high-density lipoprotein cholesterol and progression to arterial stiffness in middle-aged and elderly Chinese. Nutr. Metab. Carbiovasc. Dis. 23, 973–979 (2013). [DOI] [PubMed] [Google Scholar]
  31. Lin W. Y. et al. In addition to insulin resistance and obesity, brachial-ankle pulse wave velocity is strongly associated with metabolic syndrome in Chinese--a population-based study (Taichung Community Health Study, TCHS). J. Atheroscler. Thromb. 16, 105–112 (2009). [DOI] [PubMed] [Google Scholar]
  32. Li X. et al. Can we early diagnose metabolic syndrome using brachial-ankle pulse wave velocity in community population? Chin Med J (Engl) 127, 3116–3120 (2014). [PubMed] [Google Scholar]
  33. Wang F. et al. Waist circumference, body mass index and waist to hip ratio for prediction of the metabolic syndrome in Chinese. Nutr. Metab. Carbiovasc. Dis. 19, 542–547 (2009). [DOI] [PubMed] [Google Scholar]
  34. Sun N., Zhang Y., Tian J. L. & Wang H. Relationship between uric acid and arterial stiffness in the elderly with metabolic syndrome components. Chin Med J (Engl) 126, 3097–3102 (2013). [PubMed] [Google Scholar]
  35. Deetman P. E., Bakker S. J. & Dullaart R. P. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc. Diabetol. 12, 166 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Nagahama K. et al. Hyperuricemia predicts future metabolic syndrome: a 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens. Res. 37, 232–238 (2013). [DOI] [PubMed] [Google Scholar]
  37. Moller D. E. & Kaufman K. D. Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 45–62 (2005). [DOI] [PubMed] [Google Scholar]
  38. Grundy S. M. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: Executive Summary. Annu. Rev. Med. 4, 198–203 (2005). [DOI] [PubMed] [Google Scholar]
  39. Jha H. C., Divya A., Prasad J. & Mittal A. Plasma circulatory markers in male and female patients with coronary artery disease. Heart Lung 39, 296–303 (2010). [DOI] [PubMed] [Google Scholar]
  40. Purkayastha S. & Cai D. Neuroinflammatory basis of metabolic syndrome. Mol Metab 2, 356–363 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Despres J. P. & Lemieux I. Abdominal obesity and metabolic syndrome. Nature 444, 881–887 (2006). [DOI] [PubMed] [Google Scholar]
  42. Turati F. et al. Metabolic syndrome and hepatocellular carcinoma risk. Br. J. Cancer 108, 222–228 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES